Skip to main content

Table 4 The correlations between the different assessment parameters and the treatment outcome in the studied patients

From: Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease

Parameter EULAR good response Remission Sustained response
At 6 months At 6 months At 2 years
Disease duration r = − 0.16 r = −0.05 r = − 0.10
P > 0.05 P > 0.05 P > 0.05
Positive IgM RF at baseline r = 0.30 r = 0.31 r = 0.30
P = < 0.05* P < 0.05* P < 0.05*
Positive Anti-CCP at baseline r = 0.18 r = 0.08 r = 0.14
P > 0.05 P = 0.35 P > 0.05
Baseline Hemoglobin r = 0.39 r = 0.30 r = 0.33
P < 0.05* P < 0.05* P < 0.05*
Baseline DAS 28 r = − 0.81 r = − 0.74 r = − 0.85
P < 0.01** P <0.01** P < 0.01*
Baseline HAQ r = − 0.08 r = − 0.18 r = − 0.74
P > 0.05 P < 0.05* P < 0.01**
Baseline VAS r = 0.12 r = − 0.06 r = − 0.17
P > 0.05 P > 0.05 P > 0.05
Baseline Radiographic erosions r = − 0.75 r = − 0.80 r = − 0.77
P < 0.01** P = 0.01** P <0.01**
Declining RF titers r = 0.33 r = 0.30 r = 0.30
P <0.05* P < 0.05* P < 0.05*
  1. *P-value: significant < 0.05. **P-value: highly significant < 0.01. Abbreviations: ESR: erythrocyte sedimentation rate, HAQ: health assessment questionnaire, DAS: disease activity score, VAS: visual analogue scale.